Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q4 2016 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$115.85K$115.85Kderived+58.1% vs Q4 2015 Net Income-$1.69M-$1.69MderivedN/M vs Q4 2015 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$917,705N/M Operating Cash Flowderived-$368,504N/M Free Cash Flowderived-$493,503— Margins · derivedOperating margin-792.2%+157.6 pt vs Q4 2015
Net margin-1461.2%−1468.6 pt vs Q4 2015
ended Dec 31, 2016 · filed Apr 13, 2017 · 103 d after period end